Bausch + Lomb Corporation (BLCO)
NYSE: BLCO · Real-Time Price · USD
13.50
-0.13 (-0.95%)
Aug 1, 2025, 4:00 PM - Market closed
Revance Therapeutics Market Cap
Bausch + Lomb has a market cap or net worth of $4.78 billion as of August 1, 2025. Its market cap has decreased by -18.50% in one year.
Market Cap
4.78B
Enterprise Value
9.47B
1-Year Change
-18.50%
Ranking
Category
Stock Price
$13.50
Market Cap Chart
Since the IPO on May 6, 2022, Bausch + Lomb's market cap has decreased from $6.30B to $4.78B, a decrease of -24.17%. That is a compound annual growth rate of -8.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2025 | 4.82B | -24.17% |
| Dec 31, 2024 | 6.36B | 6.25% |
| Dec 29, 2023 | 5.99B | 10.27% |
| Dec 30, 2022 | 5.43B | -13.83% |
| May 6, 2022 | 6.30B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 679.83B |
| Johnson & Johnson | 399.88B |
| AbbVie | 343.21B |
| AstraZeneca | 232.21B |
| Novartis AG | 224.47B |
| Abbott Laboratories | 221.77B |
| UnitedHealth Group | 220.26B |
| Novo Nordisk | 213.92B |